Drug Approval | May 01, 2025
Strides receives USFDA approval for anti-inflammatory Celecoxib Capsules
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
The Subsidiary has received one inspectional observation in Form 483
This Product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension
This approval authorizes the company to export Ibuprofen to the Chinese markets
The inspection concluded with 6 observations and none of them were related to Data Integrity
Planned acquisition will strengthen the presence of Merck Healthcare in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide
Distribution agreement enables FUJIFILM India to offer Spectra Logic advanced tape libraries and software solutions to enterprise customers and channel partners
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease
The implementation, spearheaded by Deloitte Consulting, brings together domain expertise and cutting-edge technology
Subscribe To Our Newsletter & Stay Updated
